Stocks and Investing Stocks and Investing
Fri, August 5, 2016
Thu, August 4, 2016
Wed, August 3, 2016
Tue, August 2, 2016
Mon, August 1, 2016
Fri, July 29, 2016
Thu, July 28, 2016

Matthew Harrison Maintained (VRTX) at Buy with Decreased Target to $139 on, Jul 28th, 2016


Published on 2024-10-25 17:46:51 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Decreased Target from $140 to $139 on, Jul 28th, 2016.

Matthew has made no other calls on VRTX in the last 4 months.



There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, all agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Do Kim of "BMO Capital" Initiated at Hold on, Thursday, April 7th, 2016